DK0699204T3 - Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata - Google Patents

Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata

Info

Publication number
DK0699204T3
DK0699204T3 DK94918168T DK94918168T DK0699204T3 DK 0699204 T3 DK0699204 T3 DK 0699204T3 DK 94918168 T DK94918168 T DK 94918168T DK 94918168 T DK94918168 T DK 94918168T DK 0699204 T3 DK0699204 T3 DK 0699204T3
Authority
DK
Denmark
Prior art keywords
treatment
halogen
prostate
indolocarbazole derivatives
co2ch3
Prior art date
Application number
DK94918168T
Other languages
Danish (da)
English (en)
Inventor
Chikara Murakata
Craig A Dionne
Patricia C Contreras
Original Assignee
Cephalon Inc
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc, Kyowa Hakko Kogyo Kk filed Critical Cephalon Inc
Application granted granted Critical
Publication of DK0699204T3 publication Critical patent/DK0699204T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94918168T 1993-05-28 1994-05-27 Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata DK0699204T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6917893A 1993-05-28 1993-05-28
US9662293A 1993-07-22 1993-07-22
PCT/US1994/006082 WO1994027982A1 (en) 1993-05-28 1994-05-27 Use of indolocarbazole derivatives to treat a pathological condition of the prostate

Publications (1)

Publication Number Publication Date
DK0699204T3 true DK0699204T3 (da) 1999-02-22

Family

ID=26749764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918168T DK0699204T3 (da) 1993-05-28 1994-05-27 Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata

Country Status (14)

Country Link
US (2) US5516771A (ja)
EP (2) EP0839814A3 (ja)
JP (2) JP3344586B2 (ja)
KR (1) KR100201343B1 (ja)
AT (1) ATE165097T1 (ja)
AU (1) AU679752B2 (ja)
CA (1) CA2163904C (ja)
DE (1) DE69409641T2 (ja)
DK (1) DK0699204T3 (ja)
ES (1) ES2118414T3 (ja)
FI (2) FI113537B (ja)
NO (1) NO306902B1 (ja)
NZ (1) NZ267337A (ja)
WO (1) WO1994027982A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756494A (en) * 1992-07-24 1998-05-26 Cephalon, Inc. Protein kinase inhibitors for treatment of neurological disorders
DE4243321A1 (de) * 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
EP0695755B1 (en) * 1994-08-04 1998-10-21 F. Hoffmann-La Roche AG Pyrrolocarbazole
US5686444A (en) * 1995-04-05 1997-11-11 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles
US5650407A (en) * 1995-04-05 1997-07-22 Cephalon, Inc. Selected soluble esters of hydroxyl-containing indolocarbazoles
US6676935B2 (en) 1995-06-27 2004-01-13 Cell Genesys, Inc. Tissue specific adenoviral vectors
US6197293B1 (en) 1997-03-03 2001-03-06 Calydon, Inc. Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
US5808060A (en) * 1995-12-11 1998-09-15 Cephalon, Inc. Fused isoindolones
CN1233177A (zh) 1996-05-01 1999-10-27 伊莱利利公司 Vegf相关疾病的治疗
US6875865B1 (en) 1996-06-03 2005-04-05 Cephalon, Inc. Selected derivatives of K-252a
UA67725C2 (en) 1996-06-03 2004-07-15 Cephalon Inc K-252a derivatives and a method for improvement of functioning and cell survival enhancement
US6184217B1 (en) 1996-06-25 2001-02-06 Cephalon, Inc. Use of K-252a derivative
CN1147317C (zh) * 1997-08-15 2004-04-28 赛福伦公司 含酪氨酸激酶抑制剂和化学阉割剂的组合物及其用于制药的用途
JP4405667B2 (ja) 1997-12-31 2010-01-27 セフアロン・インコーポレーテツド Ｋ−２５２ａの３’−エピマー誘導体
US6127401A (en) * 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6200968B1 (en) * 1998-08-06 2001-03-13 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
US7795246B2 (en) * 1998-08-06 2010-09-14 Cephalon, Inc. Particle-forming compositions containing fused pyrrolocarbazoles
CN1329034C (zh) 1998-09-25 2007-08-01 赛福伦公司 预防/治疗感觉毛细胞和耳蜗神经元损伤的药物
WO2000024415A2 (en) * 1998-10-28 2000-05-04 Cornell Research Foundation, Inc. Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
US6841567B1 (en) 1999-02-12 2005-01-11 Cephalon, Inc. Cyclic substituted fused pyrrolocarbazoles and isoindolones
WO2001010440A1 (en) * 1999-08-09 2001-02-15 Trustees Of Dartmouth College COMPOSITIONS AND METHODS TO ENHANCE CANCER CHEMOTHERAPY IN p53 DEFECTIVE TUMORS
US6399780B1 (en) 1999-08-20 2002-06-04 Cephalon, Inc. Isomeric fused pyrrolocarbazoles and isoindolones
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
US7018999B2 (en) * 2001-05-16 2006-03-28 Cephalon, Inc. Methods for the treatment and prevention of pain
IL144583A0 (en) 2001-07-26 2002-05-23 Peptor Ltd Chimeric protein kinase inhibitors
IL156429A0 (en) * 2003-06-12 2004-01-04 Peptor Ltd Cell permeable conjugates of peptides for inhibition of protein kinases
JP2009511524A (ja) 2005-10-11 2009-03-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング ケモカイン発現のｅｇｆｒ依存調節ならびに腫瘍とその副作用の治療及び診断に与えるケモカイン発現調節の影響
US20080021013A1 (en) * 2006-07-21 2008-01-24 Cephalon, Inc. JAK inhibitors for treatment of myeloproliferative disorders
WO2009067221A2 (en) * 2007-11-20 2009-05-28 Cephalon, Inc. Microemulsion containing indolocarbazole compound and dosage forms containing the same
WO2014095088A1 (en) 2012-12-21 2014-06-26 Sykehuset Sørlandet Hf Egfr targeted therapy of neurological disorders and pain

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62155284A (ja) * 1985-12-27 1987-07-10 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
JPS62155285A (ja) * 1985-12-27 1987-07-10 Kyowa Hakko Kogyo Co Ltd 生理活性物質ｋ−２５２の誘導体
JPS62240689A (ja) * 1986-04-07 1987-10-21 Meiji Seika Kaisha Ltd Ｓｆ−２３７０物質誘導体及びその製法
JPH0826036B2 (ja) * 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
JPH0826037B2 (ja) * 1987-01-22 1996-03-13 協和醗酵工業株式会社 生理活性物質ｋ−２５２の誘導体
WO1988007045A1 (en) * 1987-03-09 1988-09-22 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance k-252
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
DE3803620A1 (de) * 1988-02-06 1989-08-17 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
US5073633A (en) * 1989-03-23 1991-12-17 Bristol-Myers Company BMY-41950 antitumor antibiotic
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung
WO1993000909A1 (en) * 1991-07-03 1993-01-21 Regeneron Pharmaceuticals, Inc. Method and assay system for neurotrophin activity
WO1993008809A1 (en) * 1991-11-08 1993-05-13 The University Of Southern California Compositions containing k-252 compounds for potentiation of neurotrophin activity
US6271242B1 (en) * 1992-02-10 2001-08-07 Bristol-Myers Squibb Co. Method for treating cancer using a tyrosine protein kinase inhibitor
US5461146A (en) * 1992-07-24 1995-10-24 Cephalon, Inc. Selected protein kinase inhibitors for the treatment of neurological disorders

Also Published As

Publication number Publication date
US5654427A (en) 1997-08-05
JP2002504064A (ja) 2002-02-05
NO306902B1 (no) 2000-01-10
JP3727613B2 (ja) 2005-12-14
AU6960794A (en) 1994-12-20
CA2163904C (en) 2000-01-25
US5516771A (en) 1996-05-14
AU679752B2 (en) 1997-07-10
NZ267337A (en) 2005-01-28
EP0699204A4 (en) 1996-01-10
ES2118414T3 (es) 1998-09-16
FI114864B (fi) 2005-01-14
FI20031516A (fi) 2003-10-16
EP0839814A2 (en) 1998-05-06
FI113537B (fi) 2004-05-14
KR960702838A (ko) 1996-05-23
EP0699204A1 (en) 1996-03-06
JP3344586B2 (ja) 2002-11-11
WO1994027982A1 (en) 1994-12-08
CA2163904A1 (en) 1994-12-08
EP0839814A3 (en) 1998-09-16
NO954816D0 (no) 1995-11-27
ATE165097T1 (de) 1998-05-15
DE69409641T2 (de) 1998-11-26
KR100201343B1 (ko) 1999-06-15
JP2002356487A (ja) 2002-12-13
FI955709A (fi) 1996-01-03
EP0699204B1 (en) 1998-04-15
NO954816L (no) 1996-01-26
DE69409641D1 (de) 1998-05-20
FI955709A0 (fi) 1995-11-27

Similar Documents

Publication Publication Date Title
DK0699204T3 (da) Anvendelse af indolocarbazolderivater til behandling af en patologisk tilstand i prostata
FI911443A0 (fi) Foerfarande foer framstaellning av 3,5-di-tert.butyl-4-hydroxifenylmetylenderivat av 2-substituerade tiazolidinoner, oxazolidinoner och imidazolidinoner med antiinflammatorisk aktivitet.
EP0704437A3 (en) Red-shifted tris-aryl-s-triazines and thus stabilized compositions
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69104593T2 (de) Herstellung und Verwendung von N-Jodopropargyl-oxycarbonylaminosäure-Estern als antimicrobielle Mittel.
ES2110213T3 (es) Derivado de n-acilglutamina.
ATE89003T1 (de) Dioxaphosphorin-verbindungen und damit stabilisierte polyolefin-zusammensetzungen.
ES2038668T3 (es) Vasodilatadores de benzotiazepina dotados de sustitucion aralquilica.
DE69725347D1 (de) Amino- und hydroxy-substituierte triphenyl-s-triazine als stabilisatoren
NO821348L (no) 4`-halogensubstituerte sukrosederivater.
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
FI810145L (fi) Nya substituerade 1,8-dihydroxi-9-(10h)antracenoner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
DK0963998T3 (da) Azasteroidforbindelse til behandling eller prævention af prostatacancer
FI852249A0 (fi) Foerfarande foer framstaellning av nya isoxazolokinolinoner.
ATE28876T1 (de) Triorganozinnacetylsalicylate und diese enthaltende biozide mittel.
MX9702211A (es) Hidroxifenil triazinas.